AKBA - Akebia Therapeutics, Inc. (AKBA) Q2 2025 Earnings Call Transcript

2025-08-07 19:34:09 ET

Akebia Therapeutics, Inc. (AKBA)

Q2 2025 Earnings Conference Call

August 07, 2025 08:00 AM ET

Company Participants

Erik John Ostrowski - Chief Business Officer, Senior VP, CFO & Treasurer

John P. Butler - CEO, President & Director

Mercedes Carrasco - Senior Director of Investor & Corporate Communications

Nicholas Grund - Senior VP & Chief Commercial Officer

Conference Call Participants

Julian Reed Harrison - BTIG, LLC, Research Division

Mazahir Lukman Alimohamed - Leerink Partners LLC, Research Division

Roger Song - Jefferies LLC, Research Division

Presentation

Operator

Good day and thank you for standing by. Welcome to the Akebia Second Quarter 2025 Financial Results. [Operator Instructions] Please be advised that today's call is being recorded....

For further details see: